{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:37:48Z","timestamp":1779100668090,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.intimp.2013.03.010","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T05:02:52Z","timestamp":1364274172000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats"],"prefix":"10.1016","volume":"16","author":[{"given":"Li-Qing","family":"Bi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Rong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ping","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.03.010_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jacc.2009.04.009","article-title":"Development and pathology of pulmonary hypertension","volume":"54","author":"Tuder","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.03.010_bb0015","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.102.22.2781","article-title":"Primary pulmonary hypertension: a vascular biology and translational research \u201cWork in progress\u201d","volume":"102","author":"Archer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.03.010_bb0020","first-page":"376","article-title":"Coagulation and anticoagulation in pulmonary arterial hypertension","volume":"11","author":"Berger","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.intimp.2013.03.010_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","article-title":"Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats","volume":"54","author":"Csiszar","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2013.03.010_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1211\/0022357011775802","article-title":"Ruscogenin glycoside (Lm-3) isolated from Liriope muscari improves liver injury by dysfunctioning liver-infiltrating lymphocytes","volume":"53","author":"Wu","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1248\/bpb.28.1234","article-title":"Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents","volume":"28","author":"Kou","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.intimp.2013.03.010_bb0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1248\/bpb.29.1267","article-title":"Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents","volume":"29","author":"Kou","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.intimp.2013.03.010_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.intimp.2011.10.018","article-title":"Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-kappaB","volume":"12","author":"Sun","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1254\/jphs.08083FP","article-title":"Possible mechanism of the anti-inflammatory activity of ruscogenin: role of intercellular adhesion molecule-1 and nuclear factor-\u03baB","volume":"108","author":"Huang","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.intimp.2013.03.010_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1254\/jphs.10076SC","article-title":"Ruscogenin mainly inhibits nuclear factor-\u03baB but not Akt and mitogen-activated protein kinase signaling pathways in human umbilical vein endothelial cells","volume":"113","author":"Song","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.intimp.2013.03.010_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00210-006-0087-9","article-title":"How valid are animal models to evaluate treatments for pulmonary hypertension?","volume":"373","author":"Campian","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0065","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.lfs.2004.03.031","article-title":"Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic rats","volume":"75","author":"Xie","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.intimp.2013.03.010_bb0070","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5223(19)38415-6","article-title":"Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery","volume":"87","author":"Wagenvoort","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.intimp.2013.03.010_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.phrs.2009.04.007","article-title":"Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway","volume":"60","author":"Shen","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2013.03.010_bb0080","first-page":"1","article-title":"Acute seizures in old age leads to a greater loss of CA1 pyramidal neurons, an increased propensity for developing chronic TLE and a severe cognitive dysfunction","volume":"2","author":"Hattiangady","year":"2011","journal-title":"Aging Dis"},{"key":"10.1016\/j.intimp.2013.03.010_bb0085","first-page":"94","article-title":"Changes of pulmonary arterial endothelial cells in chronic hypoxic rats and intervention of iptakalim hydrochloride","volume":"9","author":"Qi","year":"2005","journal-title":"Chin J Clin Rehabil"},{"key":"10.1016\/j.intimp.2013.03.010_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.106.655837","article-title":"Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation","volume":"115","author":"Sahara","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.03.010_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12016-011-8265-z","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","volume":"44","author":"Kherbeck","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1164\/ajrccm.157.3.9707095","article-title":"Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines","volume":"157","author":"Lesprit","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0105","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1073\/pnas.161272598","article-title":"Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia","volume":"98","author":"Minamino","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.03.010_bb0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/ajrccm.163.2.2006093","article-title":"40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats","volume":"163","author":"Nishimura","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0115","first-page":"56","article-title":"Monocrotaline-induced pulmonary hypertension in Wistar rats","volume":"5","author":"Rey","year":"2009","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1165\/ajrcmb.11.6.7946395","article-title":"Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline","volume":"11","author":"Voelkel","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0125","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1164\/ajrccm.162.6.2002018","article-title":"Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats","volume":"162","author":"Faul","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vph.2012.07.006","article-title":"Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB pathway in rats","volume":"58","author":"Wang","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0135","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2013.03.010_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2184.2008.00517.x","article-title":"Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases","volume":"41","author":"Ibe","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1016\/j.intimp.2013.03.010_bb0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/CIRCULATIONAHA.105.591321","article-title":"Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia","volume":"113","author":"Eddahibi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.03.010_bb0150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.freeradbiomed.2006.05.009","article-title":"Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells","volume":"41","author":"Chen","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00210-006-0082-1","article-title":"The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS","volume":"373","author":"Guerard","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2011.05.035","article-title":"Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt\/eNOS signaling and asymmetric dimethylarginine metabolism","volume":"666","author":"Pei","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2013.03.010_bb0170","doi-asserted-by":"crossref","first-page":"e33367","DOI":"10.1371\/journal.pone.0033367","article-title":"Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension","volume":"7","author":"Gaetano","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.03.010_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01902140903104793","article-title":"Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension","volume":"36","author":"Huang","year":"2010","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.intimp.2013.03.010_bb0180","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1046\/j.1538-7836.2003.00345.x","article-title":"Nitric oxide in vascular biology","volume":"1","author":"Walford","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.intimp.2013.03.010_bb0185","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000141576.39579.23","article-title":"Disruption of endothelial-cell caveolin-1alpha\/raft scaffolding during development of monocrotaline-induced pulmonary hypertension","volume":"110","author":"Mathew","year":"2004","journal-title":"Circulation"},{"issue":"A1332","key":"10.1016\/j.intimp.2013.03.010_bb0190","first-page":"711.13","article-title":"Monocrotaline disrupts caveolar-based signaling molecules contributing to impaired eNOS. (Abstract)","volume":"19","author":"Mathew","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.intimp.2013.03.010_bb0195","doi-asserted-by":"crossref","first-page":"573432","DOI":"10.1155\/2011\/573432","article-title":"Cell-specific dual role of caveolin-1 in pulmonary hypertension","volume":"2011","author":"Mathew","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.intimp.2013.03.010_bb0200","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10641963.2012.681728","article-title":"Erythropoietin, but not asialoerythropoietin or carbamyl-erythropoietin, attenuates monocrotaline-induced pulmonary hypertension in rats","volume":"34","author":"Ikarashi","year":"2012","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.intimp.2013.03.010_bb0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.RES.0000136344.27825.72","article-title":"Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis","volume":"95","author":"Sonveaux","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2013.03.010_bb0210","first-page":"706","article-title":"Effects of ruscogenin on adhesion of HL-60 cells to ECV304 cells","volume":"22","author":"Ma","year":"2006","journal-title":"Chin Pharmacol Bull"},{"key":"10.1016\/j.intimp.2013.03.010_bb0215","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2005-08-3130","article-title":"Roles of protease-activated receptors in a mouse model of endotoxemia","volume":"107","author":"Camerer","year":"2006","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T10:02:29Z","timestamp":1595584949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1567576913000957"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.03.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}